Advances in Integrative Medicine (AIM)

Advances in Integrative Medicine is a quarterly, peer-reviewed scientific journal published by Elsevier Ltd. that disseminates evidence-based research and review articles in the field of integrative and complementary medicine. First launched in 2014, the journal appears four times per year, providing a forum for rigorous quantitative and qualitative studies — including clinical trials, systematic reviews, surveys, hypotheses, and clinically relevant case reports — with practical applications in holistic healthcare. It aims to bridge conventional medical approaches with complementary therapies, promoting cross-disciplinary collaboration to improve patient outcomes and foster innovation in clinical practice. The journal is indexed with Print ISSN 2212-9588 and Online E-ISSN 2212-9596, and offers global access through Elsevier’s ScienceDirect platform. Under the editorial leadership of Susan Arentz, PhD, from the NICM Health Research Institute at Western Sydney University, the journal maintains rigorous academic standards and contributes to the scientific advancement of integrative medicine disciplines. As part of Elsevier’s portfolio of medical and healthcare journals, Advances in Integrative Medicine serves researchers, clinicians, and policy-makers seeking evidence-based insight into the integration of complementary and conventional therapeutic practices.

Advances in Integrative Medicine (AIM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Complementary and alternative medicine, reviews, clinical trials, and case studies in the field of integrative and complementary medicine, aimed at advancing interdisciplinary practice, improving patient health outcomes , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2212-9588, E-ISSN: 2212-9596, Established: 2014, Impact Factor: 1.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE